Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls.

Freddy CalderaKeith L KnutsonSumona SahaArnold WaldHiep S PhanKelly ChunIan GrimesMegan LutzMary S HayneyFrancis A Farraye

Published in: The American journal of gastroenterology (2021)

Almost all patients with IBD in our study mounted an antibody response. Future studies are needed in evaluating sustained humoral immunity and the impact of booster dosing in patients with IBD.

Keyphrases

patients with inflammatory bowel disease
immune response
coronavirus disease
sars cov
ulcerative colitis
current status
binding protein
case control